Evidence map›Paper›PMID 26248668›Full record

ArticleRetrovirology2015

Determinants in HIV-2 Env and tetherin required for functional interaction.

Colin M Exline, Su Jung Yang, Kevin G Haworth, Srinivas Rengarajan, Lisa A Lopez, Magali E Droniou, Eduardo Seclen, Paula M Cannon

Open access · goldAbstract read
In one paragraph

Article in Retrovirology, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.8field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 9 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Colin M ExlineDepartment of Molecular Microbiology and Immunology, Keck School of Medicine, University of Southern California, 2011 Zonal Avenue, HMR 502, Los Angeles, CA, 90033, USA. colinexline@gmail.com.
Su Jung YangDepartment of Molecular Microbiology and Immunology, Keck School of Medicine, University of Southern California, 2011 Zonal Avenue, HMR 502, Los Angeles, CA, 90033, USA. suyang@usc.edu.
Kevin G HaworthDepartment of Molecular Microbiology and Immunology, Keck School of Medicine, University of Southern California, 2011 Zonal Avenue, HMR 502, Los Angeles, CA, 90033, USA. khaworth@fredhutch.org.
Srinivas RengarajanDepartment of Molecular Microbiology and Immunology, Keck School of Medicine, University of Southern California, 2011 Zonal Avenue, HMR 502, Los Angeles, CA, 90033, USA. srinivas.rengarajan@gmail.com.
Lisa A LopezDepartment of Molecular Microbiology and Immunology, Keck School of Medicine, University of Southern California, 2011 Zonal Avenue, HMR 502, Los Angeles, CA, 90033, USA. lalopezphd@gmail.com.
Magali E DroniouDepartment of Molecular Microbiology and Immunology, Keck School of Medicine, University of Southern California, 2011 Zonal Avenue, HMR 502, Los Angeles, CA, 90033, USA. magali.droniou@stilla.fr.
Eduardo SeclenDepartment of Molecular Microbiology and Immunology, Keck School of Medicine, University of Southern California, 2011 Zonal Avenue, HMR 502, Los Angeles, CA, 90033, USA. seclen@usc.edu.
Paula M CannonDepartment of Molecular Microbiology and Immunology, Keck School of Medicine, University of Southern California, 2011 Zonal Avenue, HMR 502, Los Angeles, CA, 90033, USA. pcannon@usc.edu.
University of Southern California · US

Funding

Understanding how HIV-1 Vpu and HIV-2 Env stimulate virus releaseR01AI068546 · NIAID · UNIVERSITY OF SOUTHERN CALIFORNIA · PI CANNON, PAULA M · 2006 to 2010
$1.6M
NIAID NIH HHS AI068546NIAID NIH HHS R01 AI068546
6 · The paper itself

Abstract

backgroundThe interferon-inducible factor BST-2/tetherin blocks the release of nascent virions from the surface of infected cells for certain enveloped virus families. The primate lentiviruses have evolved several counteracting mechanisms which, in the case of HIV-2, is a function of its Env protein. We sought to further understand the features of the Env protein and tetherin that are important for this interaction, and to evaluate the selective pressure on HIV-2 to maintain such an activity.

resultsBy examining Env mutants with changes in the ectodomain of the protein (virus ROD14) or the cytoplasmic tail (substitution Y707A) that render the proteins unable to counteract tetherin, we determined that an interaction between Env and tetherin is important for this activity. Furthermore, this Env-tetherin interaction required an alanine face in the tetherin ectodomain, although insertion of this domain into an artificial tetherin-like protein was not sufficient to confer sensitivity to the HIV-2 Env. The replication of virus carrying the ROD14 substitutions was significantly slower than the matched wild-type virus, but it acquired second-site mutations during passaging in the cytoplasmic tail of Env which restored the ability of the protein to both bind to and counteract tetherin.

conclusionsThese results shed light on the interaction between HIV-2 and tetherin, suggesting a physical interaction that maps to the ectodomains of both proteins and indicating a strong selection pressure to maintain an anti-tetherin activity in the HIV-2 Env.

Indexed as

Amino Acid MotifsAntigens, CDBone Marrow Stromal Antigen 2env Gene Products, Human Immunodeficiency VirusGPI-Linked ProteinsHEK293 CellsHIV-2Host-Pathogen InteractionsHumansMutationProtein Interaction Domains and MotifsViral Regulatory and Accessory ProteinsVirionVirus ReplicationAntigens, CDBone Marrow Stromal Antigen 2BST2 protein, humanenv Gene Products, Human Immunodeficiency VirusGPI-Linked ProteinsViral Regulatory and Accessory Proteins

Identifiers

PMID26248668
PMCPMC4528709
OpenAlexW1959060545

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.